.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
McKesson
Daiichi Sankyo
Cantor Fitzgerald
Fuji
Johnson and Johnson
Mallinckrodt
Accenture
Chubb

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204154

« Back to Dashboard
NDA 204154 describes IVERMECTIN, which is a drug marketed by Edenbridge Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the IVERMECTIN profile page.

The generic ingredient in IVERMECTIN is ivermectin. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ivermectin profile page.

Summary for NDA: 204154

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 204154

Suppliers and Packaging for NDA: 204154

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IVERMECTIN
ivermectin
TABLET;ORAL 204154 ANDA Edenbridge Pharmaceuticals, LLC 42799-806 42799-806-01 2 BLISTER PACK in 1 CARTON (42799-806-01) > 10 TABLET in 1 BLISTER PACK
IVERMECTIN
ivermectin
TABLET;ORAL 204154 ANDA Bryant Ranch Prepack 63629-7275 63629-7275-1 2 TABLET in 1 BOTTLE (63629-7275-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG
Approval Date:Oct 24, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Medtronic
Chinese Patent Office
AstraZeneca
Farmers Insurance
Cantor Fitzgerald
Harvard Business School
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot